• Profile
Close

Protection by vaccination of children against typhoid fever with a Vi-tetanus toxoid conjugate vaccine in urban Bangladesh: A cluster-randomised trial

The Lancet Aug 26, 2021

Qadri F, Khanam F, Liu X, et al. - Children vaccinated with Vi-TT between 9 months and less than 16 years, show protection against typhoid fever.

  • In this participant-masked and observer-masked cluster-randomized trial, 150 clusters, each with approximately 1,350 residents, were randomly assigned (1:1) to either Vi-TT or SA 14-14-2 Japanese encephalitis (JE) vaccine.

  • In JE vaccines and Vi-TT vaccines, typhoid fever (cases per 100,000 person-years) incidence of 635 and 96 was recorded, respectively (total Vi-TT protection 85%).

  • Different age groups, including children vaccinated at ages under 2 years, showed consistent total vaccine protection (81%).

  • The incidence was 213 and 93 among all residents in the JE clusters and in the Vi-TT clusters, respectively.

  • No significant indirect vaccine protection by Vi-TT was evident.

  • Participants showed good tolerability towards the vaccines, and did not experience any serious adverse events judged to be vaccine-related.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay